(Q38016736)

27 August 2017

Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up (English)

1 reference

27 August 2017

Z Birsin Özçakar

1

1 reference

27 August 2017

Selçuk Yüksel

series ordinal

2

1 reference

27 August 2017

Mesiha Ekim

series ordinal

3

1 reference

27 August 2017

Fatoş Yalçınkaya

series ordinal

4

1 reference

27 August 2017

7 June 2012

1 reference

27 August 2017

Clinical Rheumatology

1 reference

27 August 2017

31

1 reference

27 August 2017

8

1 reference

27 August 2017

1267-1271

1 reference

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study

27 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Eprodisate for the treatment of renal disease in AA amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Familial Mediterranean fever in Turkey. A report of twenty cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

21 January 2018

The systemic amyloidoses

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Familial Mediterranean fever responds well to infliximab: single case experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Amyloidosis-associated kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2009-1

Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature.

21 January 2018

1 reference

12 December 2020

[The periodic disease]

1 reference

12 December 2020

Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever

1 reference

12 December 2020

Colchicine for familial Mediterranean fever

1 reference

12 December 2020

Familial Mediterranean fever: clinical, molecular and management advancements

1 reference

12 December 2020

Treatment strategies for amyloid A amyloidosis

1 reference

12 December 2020

Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome

1 reference

12 December 2020

The role of amyloidosis in familial mediterranean fever. A population study

1 reference

12 December 2020

Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis

1 reference

12 December 2020

10.1007/S10067-012-2009-1

Identifiers

DOI

1 reference

27 August 2017

1 reference